Margaret Fleming is a seasoned professional in the field of translational science and pharmacology, currently serving as Senior Director and Translational Science Leader for Rare Diseases at Ipsen. Prior experience includes heading Translational Pharmacology for Respiratory at Novartis Institutes for BioMedical Research, contributing to Translational Pharmacology focusing on Inflammation and Remodeling at Pfizer, and working as a Research Scientist in Inflammation and Autoimmunity at Wyeth Pharmaceutical Co., Ltd. Margaret Fleming holds a PhD in biochemistry from Brandeis University.
This person is not in any offices